Aroa Biosurgery Overview
- Year Founded
-
2008
- Status
-
Public
- Employees
-
229
- Stock Symbol
-
ARX
- Investments
-
1
- Share Price
-
$0.34
- (As of Friday Closing)
Aroa Biosurgery General Information
Description
Aroa Biosurgery Ltd is a soft tissue regeneration company that develops, manufactures, and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The company is in the business of developing, manufacturing, and selling soft tissue repair products. The company's principal market is the United States, where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery, and trauma/limb salvage/tumor surgery.
Contact Information
Website
www.aroa.comCorporate Office
- 64 Richard Pearse Drive Mangere
- Auckland, 2022
- New Zealand
Corporate Office
- 64 Richard Pearse Drive Mangere
- Auckland, 2022
- New Zealand
Aroa Biosurgery Stock Performance
As of 13-Nov-2026, Aroa Biosurgery’s stock price is $0.34. Its current market cap is $119M with 351M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.34 | $0.35 | $0.32 - $0.52 | $119M | 351M | 219K |
Aroa Biosurgery Financials Summary
As of 31-Mar-2026, Aroa Biosurgery has a trailing 12-month revenue of $60.9M.
|
In Thousands, USD |
TTM 31-Mar-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 130,706 | 130,706 | 83,434 | 107,210 |
| Revenue | 60,940 | 60,940 | 50,113 | 42,066 |
| EBITDA | 6,862 | 6,862 | 1,378 | (3,700) |
| Net Income | 2,745 | 2,745 | (2,256) | (6,473) |
| Total Assets | 68,960 | 68,960 | 62,118 | 66,234 |
| Total Debt | 3,645 | 3,645 | 3,661 | 4,434 |
Aroa Biosurgery Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aroa Biosurgery Patents
Aroa Biosurgery Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024269131-A1 | Tissue graft compositions and uses thereof | Pending | 05-May-2023 | ||
| EP-4704932-A1 | Tissue graft compositions and uses thereof | Pending | 05-May-2023 | ||
| US-20260295121-A1 | Tissue graft compositions and uses thereof | Pending | 05-May-2023 | ||
| WO-2024232762-A1 | Tissue graft compositions and uses thereof | Inactive | 05-May-2023 | ||
| AU-2023900188-A0 | Methods and agents for treating respiratory inflammation and associated diseases and conditions | Inactive | 27-Jan-2023 |
Aroa Biosurgery Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aroa Biosurgery Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Aroa Biosurgery Investments (1)
Aroa Biosurgery’s most recent deal was a Joint Venture with Appulse Medical. The deal was made on 01-Jun-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Appulse Medical | 01-Jun-2018 | Joint Venture | Distributors (Healthcare) |
Aroa Biosurgery ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Devices
Subindustry
Rank
Percentile
Aroa Biosurgery Exits (1)
Aroa Biosurgery’s most recent exit was on 01-Jun-2018 from Appulse Medical. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Appulse Medical | 01-Jun-2018 | Completed |
|
Aroa Biosurgery FAQs
-
When was Aroa Biosurgery founded?
Aroa Biosurgery was founded in 2008.
-
Where is Aroa Biosurgery headquartered?
Aroa Biosurgery is headquartered in Auckland, New Zealand.
-
What is the size of Aroa Biosurgery?
Aroa Biosurgery has 229 total employees.
-
What industry is Aroa Biosurgery in?
Aroa Biosurgery’s primary industry is Medical Supplies.
-
Is Aroa Biosurgery a private or public company?
Aroa Biosurgery is a Public company.
-
What is Aroa Biosurgery’s stock symbol?
The ticker symbol for Aroa Biosurgery is ARX.
-
What is the current stock price of Aroa Biosurgery?
As of 13-Nov-2026 the stock price of Aroa Biosurgery is $0.34.
-
What is the current market cap of Aroa Biosurgery?
The current market capitalization of Aroa Biosurgery is $119M.
-
What is Aroa Biosurgery’s current revenue?
The trailing twelve month revenue for Aroa Biosurgery is $60.9M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
